Today there are new reasons to be hopeful about the fight against Alzheimer’s disease. First, according to research published in Nature Medicine, the disease may be detectable by a blood test 16 years before the onset of symptoms. Such a test, which detects certain proteins that may indicate early stages of the disease, would allow doctors to identify those individuals most at risk of developing it. Second, there is a new Alzheimer’s vaccine known as UB 311, produced by a small company, United Neuroscience, in Dublin, Ireland, that has just delivered promising results in phase two clinical trials in humans....
